# Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

> **NCT04740697** · NA · RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.

## Key facts

- **NCT ID:** NCT04740697
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-12
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04740697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04740697, "Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04740697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*